159 related articles for article (PubMed ID: 11716074)
1. Medulloblastoma displays distinct regional matrix metalloprotease expression.
Vince GH; Herbold C; Klein R; Kühl J; Pietsch T; Franz S; Roosen K; Tonn JC
J Neurooncol; 2001 Jun; 53(2):99-106. PubMed ID: 11716074
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
Kachra Z; Beaulieu E; Delbecchi L; Mousseau N; Berthelet F; Moumdjian R; Del Maestro R; Béliveau R
Clin Exp Metastasis; 1999; 17(7):555-66. PubMed ID: 10845554
[TBL] [Abstract][Full Text] [Related]
4. Localization of gelatinase activities in glioma tissues by film in situ zymography.
Takano S; Tsuboi K; Matsumura A; Sato H; Nose T
Brain Tumor Pathol; 2001; 18(2):145-50. PubMed ID: 11908871
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
6. The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain tumour cells.
Rossi M; Rooprai HK; Maidment SL; Rucklidge GJ; Pilkington GJ
Anticancer Res; 1996; 16(1):121-8. PubMed ID: 8615596
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(6B):4585-90. PubMed ID: 11210857
[TBL] [Abstract][Full Text] [Related]
8. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
9. A histochemical study on the distribution and localization of beta-glucuronidase activity in cerebral tumors.
Schiffer D; Fabiani A; Cognazzo A; Monticone GF
Acta Neuropathol; 1969; 13(1):91-6. PubMed ID: 4306527
[No Abstract] [Full Text] [Related]
10. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
11. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
12. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
Liu Z; Ivanoff A; Klominek J
Int J Cancer; 2001 Mar; 91(5):638-43. PubMed ID: 11267973
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Lampert K; Machein U; Machein MR; Conca W; Peter HH; Volk B
Am J Pathol; 1998 Aug; 153(2):429-37. PubMed ID: 9708803
[TBL] [Abstract][Full Text] [Related]
14. ATPase in human brain tumors.
Laws ER; O'Connor JS
J Neurosurg; 1970 Aug; 33(2):167-71. PubMed ID: 4319012
[No Abstract] [Full Text] [Related]
15. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.
Anthony DC; Ferguson B; Matyzak MK; Miller KM; Esiri MM; Perry VH
Neuropathol Appl Neurobiol; 1997 Oct; 23(5):406-15. PubMed ID: 9364466
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10.
Wagner S; Stegen C; Bouterfa H; Huettner C; Kerkau S; Roggendorf W; Roosen K; Tonn JC
J Neurooncol; 1998 Nov; 40(2):113-22. PubMed ID: 9892093
[TBL] [Abstract][Full Text] [Related]
17. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
Kerkelä E; Ala-aho R; Klemi P; Grénman S; Shapiro SD; Kähäri VM; Saarialho-Kere U
J Pathol; 2002 Oct; 198(2):258-69. PubMed ID: 12237887
[TBL] [Abstract][Full Text] [Related]
18. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):675-82. PubMed ID: 11212845
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.
Vince GH; Wagner S; Pietsch T; Klein R; Goldbrunner RH; Roosen K; Tonn JC
Int J Dev Neurosci; 1999; 17(5-6):437-45. PubMed ID: 10571406
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
Mercapide J; Lopez De Cicco R; Castresana JS; Klein-Szanto AJ
Int J Cancer; 2003 Sep; 106(5):676-82. PubMed ID: 12866026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
